Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products
HOME
/
Commentary & Opinion
/
Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products